United Kingdom Precision Medicine Market By Products and Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services), By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Whole Genome Sequencing, Companion Diagnostics, Next Generation Sequencing (NGS), Others), By Application (Oncology, Immunology, Cardiology, Neurology, Respiratory, Others
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationUnited Kingdom Precision Medicine Market By Products and Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services), By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Whole Genome Sequencing, Companion Diagnostics, Next Generation Sequencing (NGS), Others), By Application (Oncology, Immunology, Cardiology, Neurology, Respiratory, Others
United Kingdom precision medicine market is expected to register robust growth in the forecast period, 2023-2027.
Growing Prevalence of CNS Disorders is Projected to Augment the Market Growth
CNS ailments include Alzheimer’s disease, multiple sclerosis, epilepsy, afflict millions of individuals across the globe which is primarily driving the market growth. Dementia affects more than 50 million individuals worldwide. Alzheimer's disease, the most common kind of dementia, accounts for 60-70 percent of all cases. The growth of the industry is aided by an enhancing focus on targeted therapeutics and the development of individualized medical treatment regimens for persons suffering from CNS illnesses.
Elevating Prevalence of Cancer Across the United Kingdom Drives the Market Growth
The escalating demand for precision medicine methods across the developed countries like UK owing to the rising prevalence of cancer and the increasing number of treatment candidates in clinical trials. This, turn, is driving the market growth. In addition to this, the rising number of cases of genetic diseases will continue to influence positively the growth of precision medicine market. With this, the elevating levels of urbanization and inflating level of disposable income are accelerating the growth of the precision medicine market. The growing expenditure on healthcare infrastructure and expanding geriatric population are the major market drivers that support the growth of precision medicine market. The recent development in technologies including the ultra-high throughout sequencing and next-generation sequencing is expected to fuel the growth of the market over the future years.
Extensive R&D Activities is Anticipated to Bolster the Market Growth
The growing number of research and development activities offer lucrative opportunities for the precision medicine market growth. The enhancing focus of manufacturers on the adoption of upgraded technologies and rise in the number of emerging economies will opportunities for the precision medicine market growth in the upcoming years.
Download Sample Report
Market Segmentation
The United Kingdom precision medicine devices market is segmented into products and services, technology, application, end-user, regional distribution, and competitive landscape.
Market Players
Thermo Fischer Scientific United Kingdom, Qiagen Manchester Limited, Illumina Cambridge Limited, Quest Diagnostic Limited, Agilent Technologies UK Limited, GlaxoSmithKline Plc., Roche Diagnostics Limited are the significant market players operating in United Kingdom precision medicine devices market.
| Attribute | Details |
| Base Year | 2021 |
| Historic Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Product and Services · Technology · Application · End Use |
| Regional scope | London, Southeast, East Anglia, Scotland, Southwest, East Midlands, and Yorkshire & Humberside |
| Key companies profiled | Thermo Fischer Scientific United Kingdom, Qiagen Manchester Limited, Illumina Cambridge Limited, Quest Diagnostic Limited, Agilent Technologies UK Limited, GlaxoSmithKline Plc., Roche Diagnostics Limited |
| Customization scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy